22 results on '"Göhring, G"'
Search Results
2. P47 - Topic: AS07-Singular Entities/Subtypes/AS07c-Hereditary MDS including predisposition syndromes: HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN AND ADOLESCENTS WITH GATA2-RELATED MYELODYSPLASTIC SYNDROME
3. O27 - Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: OUTCOMES OF RELAPSED JUVENILE MYELOMONOCYTIC LEUKEMIA: THE ROLE OF SECOND HEMATOPOIETIC STEM CELL TRANSPLANTATION
4. O05 - Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: SOMATIC GENETIC RESCUE IN SAMD9/SAMD9L MDS PREDISPOSITION SYNDROMES
5. Topic: AS07-Singular Entities/Subtypes/AS07c-Hereditary MDS including predisposition syndromes
6. Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment
7. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution
8. 150 INFLUENCE OF TP53 MUTATIONS ON HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIAS (AML)
9. P-211 Splicing gene mutations in MDS and secondary AML: Clinical implications in the setting of allogeneic hematopoietic stem cell transplantation
10. P-252 Routes of clonal evolution into complex karyotypes in myelodysplastic syndrome patients with del(5q)
11. P-198 SPARC and TNF-α contribute significantly to erythroid failure in MDS with 5q deletion and influence considerably the efficacy of lenalidomide
12. P-253 Unbalanced translocation t(5;17) resulting in a TP53 loss as recurrent aberration in myelodysplastic syndrome with complex karyotype
13. O-003 ASXL1 frameshift mutations in patients with MDS and AML following MDS after allogeneic SCT: Update on 206 patients
14. 68 ASXL1 is frequently mutated and associated with a negative prognosis in MDS
15. 269 Mechanisms of action of lenalidomide on erythroblastic islands in patients with low- or intermediate-1-risk MDS with del(5q) chromosome abnormality
16. 257 Inactivation of ICSBP by promoter methylation is likely involved in progressive leukemogenesis
17. 296 Telomere shortening is associated with AML progression in patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide
18. 48 GATA2-RELATED MYELODYSPLASTIC SYNDROMES (MDS): PREVALENCE, CLINICAL CHARACTERISTICS AND PROGNOSIS
19. No evidence for ITSN1 loss in a patient with mental retardation and complex chromosomal rearrangements of 21q21-21q22.
20. Aberrant microRNA expression pattern in myelodysplastic bone marrow cells.
21. Recurrent involvement of heterochromatic regions in multiple myeloma-a multicolor FISH study.
22. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.